I have done my Ph.D. on improving the CAR T cells in the context of solid tumor therapy using the CRISPR/Cas9 technology. Part of this project was done in TRON (Translational Oncology), Mainz, Germany in Prof. Sahin's lab, where I gained a lot of experienced and developed skills in handling T cells. Joined Dr. Napolitani's lab in early 2022, we are trying to identify targets for the development of novel therapeutic strategies against Myeloma and also determine biomarkers to monitor leukemia-specific immunity.